Press "Enter" to skip to content

FDA approves new treatment for osteoporosis in postmenopausal women at high risk of fracture

FDA approves a new treatment for osteoporosis in postmenopausal women at high risk of breaking a bone (fracture).

Also Read:   Recommendations About the Use of Dental Amalgam in Certain High-Risk Populations: FDA Safety Communication